Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 2Terminated 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 5CNS 5Genitourinary 4Head & Neck 3Breast 2Tumor-Agnostic 1Other solid neoplasm 1Gynecologic 1

Conditions

Glioblastoma 4Brain Neoplasms 3Neoplasms 2Glioma 2Astrocytoma 2Camurati-Engelmann Syndrome 1

Interventions

Temozolomide 610Radiotherapy 387Bevacizumab 253Magnetic Resonance Spectroscopy 202Cyclophosphamide 177Carboplatin 159Radiosurgery 145Etoposide 132Radiation 120Irinotecan 115Vincristine 114Cisplatin 102Filgrastim 100Specimen Handling 88Nivolumab 87pembrolizumab 81Lomustine 80Topotecan 73Surgical Procedures, Operative 73Doxorubicin 60Melphalan 59Carmustine 57sargramostim 53Radiotherapy, Intensity-Modulated 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 50Erlotinib Hydrochloride 50Everolimus 48Chemotherapy, Adjuvant 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Drug Delivery Systems × CNS × Clear all
NCT07042620 2026-05-14

A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery

SonoClear AS

Phase NA Active not recruiting
15 enrolled
CNS

Glioblastoma, Glioma

NCT05733312 2026-01-30

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Mayo Clinic

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms

NCT07141732 2025-09-16

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Joint Stock Company European Medical Centre

Phase 1 Recruiting
15 enrolled
CNS

Glioblastoma

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT00431561 2013-12-03

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Isarna Therapeutics GmbH

Phase 2 Completed
141 enrolled
CNS

Astrocytoma, Brain Neoplasms, Camurati-Engelmann Syndrome, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡